BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 21121921)

  • 1. Probable cutaneous hypersensitivity to carboplatin single-agent chemotherapy in a dog.
    Lanore D; Sayag D
    J Small Anim Pract; 2010 Dec; 51(12):654-6. PubMed ID: 21121921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful desensitization to carboplatin in patients with systemic hypersensitivity reactions.
    Broome CB; Schiff RI; Friedman HS
    Med Pediatr Oncol; 1996 Feb; 26(2):105-10. PubMed ID: 8531847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe, prolonged bone marrow hypoplasia secondary to the use of carboplatin in an azotemic dog.
    Phillips B
    J Am Vet Med Assoc; 1999 Nov; 215(9):1250-2; discussion 1252-3. PubMed ID: 10553432
    [No Abstract]   [Full Text] [Related]  

  • 4. Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?
    Syrigou E; Makrilia N; Vassias A; Nikolaidis I; Xyla V; Manolopoulos L; Syrigos K
    Anticancer Drugs; 2010 Mar; 21(3):333-8. PubMed ID: 20038831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Owner's perception of carboplatin in conjunction with other palliative treatments for cancer therapy.
    Bowles DB; Robson MC; Galloway PE; Walker L
    J Small Anim Pract; 2010 Feb; 51(2):104-12. PubMed ID: 20070498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboplatin desensitization.
    Choi J; Harnett P; Fulcher DA
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):137-41. PubMed ID: 15328672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of cisplatin after severe hypersensitivity reactions to carboplatin in patients with recurrent ovarian carcinoma.
    Ottaiano A; Tambaro R; Greggi S; Prato R; Di Maio M; Esposito G; Scala F; Barletta E; Losito S; De Vivo R; Iaffaioli VR; Pignata S
    Anticancer Res; 2003; 23(4):3465-8. PubMed ID: 12926091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents.
    Lee C; Gianos M; Klaustermeyer WB
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):179-87; quiz 187-9, 222. PubMed ID: 19354063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual dermatological toxicity of hydroxyurea in two dogs with spontaneously occurring tumours.
    Marconato L; Bonfanti U; Fileccia I
    J Small Anim Pract; 2007 Sep; 48(9):514-7. PubMed ID: 17617162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I clinical trial of oral rosiglitazone in combination with intravenous carboplatin in cancer-bearing dogs.
    Allstadt Frazier S; McKemie DS; Guerrero TA; LaChapelle H; Skorupski KA; Kass PH; Rodriguez CO
    Vet Comp Oncol; 2014 Mar; 12(1):1-9. PubMed ID: 22364238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded experience with an intradermal skin test to predict for the presence or absence of carboplatin hypersensitivity.
    Markman M; Zanotti K; Peterson G; Kulp B; Webster K; Belinson J
    J Clin Oncol; 2003 Dec; 21(24):4611-4. PubMed ID: 14673050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent 5-fluorouracil and carboplatin for the treatment of canine carcinomas.
    Menard K; Flesner BK; Glahn A; Boudreaux B; Bryan JN
    Vet Comp Oncol; 2018 Dec; 16(4):590-595. PubMed ID: 30043425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Canine intranasal tumours treated with alternating carboplatin and doxorubin in conjunction with oral piroxicam: 29 cases.
    Woodruff MJ; Heading KL; Bennett P
    Vet Comp Oncol; 2019 Mar; 17(1):42-48. PubMed ID: 30146732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suspected Carboplatin Extravasation Reactions in Seven Dogs.
    Miller KB; Lejeune A; Regan R; Szivek A; Kow K
    J Am Anim Hosp Assoc; 2018; 54(6):360-367. PubMed ID: 30272477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intratumoral administration of carboplatin for treatment of squamous cell carcinomas of the nasal plane in cats.
    Théon AP; VanVechten MK; Madewell BR
    Am J Vet Res; 1996 Feb; 57(2):205-10. PubMed ID: 8633809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin.
    Fox LE
    J Am Anim Hosp Assoc; 2000; 36(1):13-4. PubMed ID: 10667400
    [No Abstract]   [Full Text] [Related]  

  • 17. Utility of delayed reading of intradermal test in carboplatin-induced drug hypersensitivity.
    D'Amelio CM; Aramendía JM; Yuste JR; Fusco JP; Gastaminza G; Goikoetxea MJ
    Ann Allergy Asthma Immunol; 2015 Jun; 114(6):534-5. PubMed ID: 26021896
    [No Abstract]   [Full Text] [Related]  

  • 18. Carboplatin hypersensitivity and desensitization in an infant.
    Montiel Herrera JM; Góngora-Melendez MA; Pineda-Maldonado ML; Medina-Sanson A; Del Rio Chivardi JM; Del Río-Navarro BE; Rosas-Vargas MA
    Ther Drug Monit; 2010 Aug; 32(4):525-8. PubMed ID: 20463633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemorrhagic cystitis in a dog receiving carboplatin.
    MacDonald V; Dickinson R
    J Am Anim Hosp Assoc; 2014; 50(1):67-70. PubMed ID: 24216493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib.
    de Vos J; Ramos Vega S; Noorman E; de Vos P
    Vet Comp Oncol; 2012 Sep; 10(3):206-13. PubMed ID: 22236048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.